Market News & Trends
Novo Nordisk & Emisphere Announce License Agreement to Develop Oral Formulation of Insulin for $57.5 Million
Emisphere Technologies, Inc. and Novo Nordisk A/S recently announced they have entered into an exclusive development and license agreement to develop and commercialize oral formulations…
Omeros Corporation Announces Positive Phase I/II Clinical Results of OMS201
Omeros Corporation, a biopharmaceutical company committed to discovering, developing, and commercializing products focused on inflammation and disorders of the central nervous system, recently announced results…
3M DDS Signs Licensing Agreement With Spirig Pharma AG
3M Drug Delivery Systems recently announced it has signed an exclusive licensing agreement with Spirig Pharma AG, a Swiss manufacturer of dermatological and dermocosmetic products.…
*Latest Events
Pre-Filled East Coast 2018 April 10-12 Boston, MA Pre Filled Syringes East Coast April 11 - 12 Boston, MA INTERPHEX April 17-19 New York City…
